Thyrotropin alfa
1 paper3 findings
- 1 lab in 1 country
- Funders: European Commission and 1 more
- Human trial1
Outcomes
3Cortisol
downin humans1
1 study
Cortisol
downin humans1
Thyrotropin alfa decreases cortisol in humans (-14.8% (SEM = 3.6%, p < 0.001)).
“cortisol (-14.8% [SEM = 3.6%, p < 0.001] and -15.6% [SEM = 3.5%, p < 0.001])”
Human trialhealthy older individualsintramuscular injection0.1 mg4 daysn = 29
NeuroendocrinologyDec 3, 2024
Prolactin
downin humans1
1 study
Prolactin
downin humans1
Thyrotropin alfa decreases prolactin in humans (-8.8% (SEM = 3.4%, p = 0.048)).
“prolactin significantly decreased in both rhTSH and T3 challenges (-8.8% [SEM = 3.4%, p = 0.048] and -12.0% [3.3%, p = 0.004], respectively)”
Human trialhealthy older individualsintramuscular injection0.1 mg4 daysn = 29
NeuroendocrinologyDec 3, 2024
IGF-1
upin humans1
1 study
IGF-1
upin humans1
Thyrotropin alfa increases IGF-1 in humans (+6.3% (SEM = 1.6%, p = 0.002)).
“IGF-1 increased with a maximum of 6.3% (SEM = 1.6%, p = 0.002) in the rhTSH challenge”
Human trialhealthy older individualsintramuscular injection0.1 mg4 daysn = 29
NeuroendocrinologyDec 3, 2024
Latest
Neuroendocrinology
Effect of Thyroid Status Modulation on Pituitary and Peripheral Hormone Concentrations in Healthy Older Subjects
Non-randomized trial in 29 peopleMechanisms